Cargando…

Immune Checkpoint Inhibitory Therapy in Sarcomas: Is There Light at the End of the Tunnel?

SIMPLE SUMMARY: Soft tissue and bone sarcomas is a very heterogeneous group of tumors that has an aggressive course, especially in the metastatic setting. In this group the therapeutic options are rather limited. Immunotherapy is nowadays used successfully for the treatment of various tumor types. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siozopoulou, Vasiliki, Domen, Andreas, Zwaenepoel, Karen, Van Beeck, Annelies, Smits, Evelien, Pauwels, Patrick, Marcq, Elly
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835811/ https://www.ncbi.nlm.nih.gov/pubmed/33478080 http://dx.doi.org/10.3390/cancers13020360

Ejemplares similares

NTRK Fusions in Sarcomas: Diagnostic Challenges and Clinical Aspects
por: Siozopoulou, Vasiliki, et al.
Publicado: (2021)

NTRK Fusions in a Sarcomas Series: Pathology, Molecular and Clinical Aspects
por: Siozopoulou, Vasiliki, et al.
Publicado: (2022)

Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma
por: Rovers, Sophie, et al.
Publicado: (2022)

Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients
por: Marcq, Elly, et al.
Publicado: (2017)

Building a Bridge between Chemotherapy and Immunotherapy in Malignant Pleural Mesothelioma: Investigating the Effect of Chemotherapy on Immune Checkpoint Expression
por: Marcq, Elly, et al.
Publicado: (2019)

Prognostic and Predictive Biomarkers in Non-Small Cell Lung Cancer Patients on Immunotherapy—The Role of Liquid Biopsy in Unraveling the Puzzle
por: Augustus, Elien, et al.
Publicado: (2021)

Light at end of the tunnel
por: Hassard, J
Publicado: (1989)

Light at the end of the tunnel
por: Manohar, Balaji
Publicado: (2013)

The Light at the End of the Tunnel
por: Mando, Rufaat, et al.
Publicado: (2019)

Light at the End of the Tunnel
por: Gupta, Piyush
Publicado: (2021)

Immune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel?
por: Paglialunga, Luca, et al.
Publicado: (2016)

The effect of local non‐thermal plasma therapy on the cancer‐immunity cycle in a melanoma mouse model
por: Lin, Abraham, et al.
Publicado: (2022)

Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect
por: Jacobs, Julie, et al.
Publicado: (2015)

2021: The Light at the End of the Tunnel?
por: Birkhoelzer, Sarah M., et al.
Publicado: (2021)

Light at the end of the tunnel of Corti
por: Hanlon, Kilian, et al.
Publicado: (2023)

Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)?
por: Hiddinga, Birgitta, et al.
Publicado: (2022)

The light at the end of the tunnel gets brighter
por: Anaïs Schaeffer
Publicado: (2014)

Coronavirus Vaccine: Light at the End of the Tunnel
por: Ella, Krishna M, et al.
Publicado: (2020)

The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3
por: Marcq, Elly, et al.
Publicado: (2021)

RNAi off-targeting: Light at the end of the tunnel
por: Brown, Kirk, et al.
Publicado: (2006)

Nitric oxide in fungi: is there NO light at the end of the tunnel?
por: Cánovas, David, et al.
Publicado: (2016)

Telemedicine shows us light at the end of the tunnel
por: Gupta, Harish, et al.
Publicado: (2021)

Working With a Psychopath: Is There Light at the End of the Tunnel?
por: Stewart, Jayme, et al.
Publicado: (2021)

CLL and COVID-19: light at the end of the tunnel?
por: Scarfò, Lydia, et al.
Publicado: (2022)

Antimicrobial Resistance: Is There a ‘Light’ at the End of the Tunnel?
por: Leanse, Leon G., et al.
Publicado: (2023)

Targeted therapies in cholangiocarcinoma: light at the end of the tunnel?
por: Amygdalos, Iakovos, et al.
Publicado: (2023)

Immunohistochemistry as a screening tool for NTRK gene fusions: results of a first Belgian ring trial
por: De Winne, Koen, et al.
Publicado: (2020)

The Role of the Cutaneous Microbiome in Hidradenitis Suppurativa—Light at the End of the Microbiological Tunnel
por: Langan, Ewan A., et al.
Publicado: (2020)

Abscisic acid (ABA) receptors: light at the end of the tunnel
por: Muschietti, Jorge, et al.
Publicado: (2010)

Light at the end of the tunnel?: The Great Indian Pharmacoeconomics story
por: Thakkar, Karan B., et al.
Publicado: (2013)

Chagas disease research and development: Is there light at the end of the tunnel?
por: Chatelain, Eric
Publicado: (2016)

Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel?
por: Mahipal, Amit, et al.
Publicado: (2019)

The Covid-19 epidemic: are there lights at the end of the long tunnel?
por: Holden, Patrick
Publicado: (2020)

Immunotherapy for pancreatic cancer: chasing the light at the end of the tunnel
por: Brouwer, Thomas P., et al.
Publicado: (2021)

The Light at the End of the Tunnel: Neurosurgery Education During COVID
por: Sharif, Salman, et al.
Publicado: (2021)

Gene Editing and Alzheimer's Disease: Is There Light at the End of the Tunnel?
por: Stepanichev, Mikhail
Publicado: (2020)

Immunotherapy in Advanced Prostate Cancer—Light at the End of the Tunnel?
por: von Amsberg, Gunhild, et al.
Publicado: (2022)

COVID control strategy–-is there any light at the end of the tunnel?
por: Sarkar, Bidisa, et al.
Publicado: (2020)

Therapy of Chronic Viral Hepatitis: The Light at the End of the Tunnel?
por: Saracco, Giorgio Maria, et al.
Publicado: (2022)

Treatments of Multidrug-Resistant Tuberculosis: Light at the End of the Tunnel
por: Lange, Christoph, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r0du6smj1ik7lbevor4r08cuct